Ovarian CancerInfo Center
Many young women today don’t worry too much about how old they will be when they have children. But for women with the gene for breast cancer, waiting to decide might have dire consequences.
Ovarian cancer is one of the most dangerous cancers of women's reproductive systems. However, a simple over-the-counter medication regimen may aid in preventing this cancer.
Because her mother had ovarian cancer, actress, director and humanitarian Angelina Jolie underwent genetic testing. Should you? The United States Preventive Services Task Force (USPSTF) issued its latest recommendations.
Women who have mutations in the BRCA genes are at higher risk of breast and ovarian cancer. Research has suggested that women with these altered genes may also have problems conceiving children and that they go through menopause earlier than women without the defective genes.
Women who carry mutations in the BRCA genes have higher risks for both breast and ovarian cancer. One way to reduce these risks is to have both their ovaries and breasts surgically removed. A new analysis looked at another possible way — birth control pills.
Sometimes cancer needs more than one kind of treatment to shrink or disappear. That’s why treatment often includes a mixture of surgery, radiation and/or chemotherapy. In a recent study, ovarian cancer responded to a double-pronged attack.
About one out of 70 women will be diagnosed with ovarian cancer in their lifetime. Surgically removing the ovaries is one way to prevent this cancer.
Let's say breast cancer runs in your family. So you decide to have genetic testing to learn your risks. The results of your test will affect your children. Would you tell your children the results or not?
If cancer returns, treatment is often to try and stall its growth. Ovarian cancer is a tough foe, but a new trial has found one medication that may help control the disease.
Even after a cancer is successfully treated, there's still a risk that another cancer may show up at some point down the line. A recent Spanish study looked at the risk of second cancers in breast cancer survivors.